cyproterone acetate has been researched along with Hyperandrogenism in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (24.44) | 18.2507 |
2000's | 8 (17.78) | 29.6817 |
2010's | 22 (48.89) | 24.3611 |
2020's | 4 (8.89) | 2.80 |
Authors | Studies |
---|---|
Álvarez-Blasco, F; de Lope Quiñones, S; Escobar-Morreale, HF; Fernández-Durán, E; Insenser, M; Luque-Ramírez, M; Martínez-García, MÁ; Nattero-Chávez, L; Ortiz-Flores, AE; Quintero-Tobar, A | 1 |
Alesi, S; Forslund, M; Melin, J; Mousa, A; Pena, A; Piltonen, T; Romualdi, D; Tay, CT; Teede, H; Witchel, S | 1 |
Plu-Bureau, G | 1 |
Broux, E; Catteau-Jonard, S; Dewailly, D | 1 |
Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
Bitzer, J; Lopes da Silva Filho, A; Römer, T | 1 |
Mueck, AO | 1 |
Asiimwe, A; Bezemer, ID; Herings, RMC; Penning-van Beest, FJA; Smits, E | 1 |
Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G | 1 |
Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
de Vries, L; Lazar, L; Lebenthal, Y; Meyerovitch, J; Phillip, M | 1 |
Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
Bettoli, V; Virgili, A; Zauli, S | 1 |
Jin, J; Mueck, AO; Ruan, X; Wu, H | 1 |
de Zegher, F; Díaz, M; Gallego-Escuredo, JM; Ibáñez, L; Villarroya, F | 1 |
Catteau-Jonard, S; Dewailly, D; Gronier, H; Peigné, M; Plouvier, P; Robin, G | 1 |
Fedorowicz, Z; van Zuuren, EJ | 1 |
Asiimwe, A; Cea Soriano, L; García Rodriguez, LA | 1 |
Cao, Y; Jiang, Y; Wu, J; Zhu, Y | 1 |
Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
Bachelot, A; Chabbert-Buffet, N; Galand-Portier, MB; Kerlan, V; Salenave, S | 1 |
Decavalas, G; Diamanti-Kandarakis, E; Georgopoulos, NA; Katsikis, I; Panidis, D; Piouka, A; Saltamavros, AD | 1 |
Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
de Zegher, F; Diaz, M; Ibáñez, L; Lopez-Bermejo, A; Salvador, C; Sánchez-Infantes, D; Sebastiani, G | 1 |
Chacón, MR; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Maymó-Masip, E; Salvador, C; Vendrell, J | 1 |
Carmina, E; Lobo, RA | 2 |
Herer, P; Luboshitzky, R; Shen-Orr, Z | 2 |
Frank-Raue, K; Schulze, E | 1 |
le Roux, PA; Van der Spuy, ZM | 1 |
Abramovici, Y; Boudou, P; Cathelineau, G; Conard, J; Consoli, S; Fiet, J; Hardy, N; Vexiau, P | 1 |
Falsetti, L; Pasinetti, E | 1 |
Neumann, F | 1 |
Gerhard, I; Matthes, J; Runnebaum, B | 1 |
Azem, F; Bar-Am, A; Grisaru, D; Inbar, M; Lessing, JB; Oren, M | 1 |
Bártfai, G; Koloszár, S; Szöllösi, J | 1 |
Balsa, J; Escobar-Morreale, HF; Pazos, F; Sancho, JM; Varela, C | 1 |
Bersi, C; Fruzzetti, F; Genazzani, AR; Parrini, D; Ricci, C | 1 |
Gjønnaess, H | 1 |
Vexiau, P | 1 |
Gogate, JG; Shringi, MS; Vaidya, AB; Vaidya, RA | 1 |
Boudou, P; Chaspoux, C; Fiet, J; Hardy, N; Jouanique, C; Reygagne, P; Vexiau, P | 1 |
9 review(s) available for cyproterone acetate and Hyperandrogenism
Article | Year |
---|---|
Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Testosterone | 2023 |
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Skin Diseases; Treatment Outcome | 2017 |
Is hormonal treatment still an option in acne today?
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Flutamide; Gonadotropin-Releasing Hormone; Hormones; Humans; Hyperandrogenism; Spironolactone | 2015 |
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult | 2016 |
Anti-androgen treatments.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Progestins; Spironolactone | 2010 |
Cyproterone acetate for hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Randomized Controlled Trials as Topic | 2003 |
The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research.
Topics: Animals; Cyproterone Acetate; Female; Humans; Hyperandrogenism; Male; Molecular Structure; Prostatic Neoplasms; Sex Differentiation; Sexual Dysfunction, Physiological | 1994 |
[Theory and practice of daily prescription and gynecologic consultation for treatment of hyperandrogenism. Indications and contraindications].
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Female; Humans; Hyperandrogenism; Progestins | 1999 |
21 trial(s) available for cyproterone acetate and Hyperandrogenism
Article | Year |
---|---|
Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bloodletting; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypertension; Polycystic Ovary Syndrome; Young Adult | 2021 |
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases | 2013 |
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.
Topics: Adolescent; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Fibroblast Growth Factors; Flutamide; Hirsutism; Humans; Hyperandrogenism; Hyperinsulinism; Longitudinal Studies; Metformin; Pioglitazone; Thiazolidinediones | 2016 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio | 2008 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Anti-Mullerian Hormone; Blood Glucose; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Practice Guidelines as Topic; Young Adult | 2011 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Body Composition; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Metformin; Pioglitazone; Thiazolidinediones; Treatment Outcome | 2011 |
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Angiopoietin-Like Protein 4; Angiopoietins; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Body Composition; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Gene Expression; Humans; Hyperandrogenism; Hypoglycemic Agents; Leptin; Metformin; Pioglitazone; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Subcutaneous Fat; Thiazolidinediones; TWEAK Receptor | 2012 |
A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Prospective Studies; Statistics, Nonparametric | 2002 |
Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Melatonin | 2002 |
Treatment of hyperandrogenic alopecia in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Italy; Liver; Testosterone | 2003 |
17 beta-Estradiol: oral or parenteral administration in hyperandrogenic women? Metabolic tolerance in association with cyproterone acetate.
Topics: Administration, Cutaneous; Administration, Oral; Angiotensinogen; Antithrombin III; Apolipoproteins; Blood Coagulation; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estrone; Female; Fibrinogen; Fibrinolysis; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Plasminogen; Premenopause; Prospective Studies; Sex Hormone-Binding Globulin | 1995 |
Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Topics: Adult; Apoproteins; Cholesterol; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipid Metabolism; Lipoproteins; Polycystic Ovary Syndrome; Pregnancy; Testosterone; Triglycerides | 1995 |
The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive.
Topics: Adult; Buserelin; Contraceptives, Oral, Combined; Cyproterone Acetate; Down-Regulation; Drug Combinations; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Infertility, Female; Infusion Pumps; Ovulation Induction | 1993 |
[Ovulation induction with adjuvant antiandrogen treatment in Stein-Leventhal syndrome].
Topics: Adult; Androgen Antagonists; Anovulation; Cyproterone Acetate; Dexamethasone; Female; Humans; Hyperandrogenism; Infertility, Female; Mineralocorticoid Receptor Antagonists; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Spironolactone | 1996 |
Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Liver Function Tests; Luteolytic Agents; Prospective Studies; Triptorelin Pamoate | 1999 |
Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Hyperandrogenism | 1999 |
Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Topics: Administration, Topical; Adult; Alopecia; Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Minoxidil | 2002 |
15 other study(ies) available for cyproterone acetate and Hyperandrogenism
Article | Year |
---|---|
[Should cyproterone acetate be removed from our prescriptions?]
Topics: Age Factors; Androgen Antagonists; Cyproterone Acetate; Female; Humans; Hyperandrogenism; Meningioma; Safety-Based Drug Withdrawals | 2019 |
[Spironolactone as a relay for cyproterone acetate in hyperandrogenic women].
Topics: Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Female; France; Humans; Hyperandrogenism; Patient Satisfaction; Retrospective Studies; Spironolactone; Testosterone | 2020 |
Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome | 2017 |
Thrombotic risk minimization for Diane-35 and generics.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Drug Utilization; Drugs, Generic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Menstruation Disturbances; Middle Aged; Netherlands; Retrospective Studies; Risk Reduction Behavior; Thrombosis; Young Adult | 2017 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades.
Topics: Adolescent; Adult; Child; Cross-Sectional Studies; Cyproterone Acetate; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Middle Aged; Pregnancy; Pregnancy Outcome; Puberty, Precocious; Triptorelin Pamoate | 2014 |
Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Topics: Adolescent; Adult; Androgen Antagonists; China; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metabolome; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2015 |
Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?
Topics: Adolescent; Adult; Androgen Antagonists; Anti-Mullerian Hormone; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Hyperandrogenism; Longitudinal Studies; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2016 |
Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; General Practice; Hirsutism; Humans; Hyperandrogenism; Off-Label Use; Polycystic Ovary Syndrome; Retrospective Studies; United Kingdom; Young Adult | 2017 |
[Hirsutism].
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Cyproterone Acetate; Dexamethasone; Diagnosis, Differential; Female; Glucocorticoids; Hirsutism; Humans; Hydrocortisone; Hyperandrogenism; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Pregnancy; Risk Factors | 2003 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
A case of severe hyperandrogenism, acanthosis nigricans and over diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management.
Topics: Acanthosis Nigricans; Adult; Amenorrhea; Cyproterone Acetate; Diabetes Mellitus, Type 2; Female; Hirsutism; Humans; Hyperandrogenism; Magnetic Resonance Imaging; Ovary; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1996 |
Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Electrocoagulation; Estrogens; Ethinyl Estradiol; Female; Gonadotropins; Humans; Hyperandrogenism; Infertility, Female; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1999 |
Development of diabetes mellitus and hypertension due to aggravation of insulin resistance after estrogen--progestogen in HAIR-AN syndrome.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Diabetes Mellitus; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Hypertension; Insulin Resistance; Progesterone Congeners; Syndrome | 1997 |